AstraZeneca
AZN
#47
Rank
S$362.34 B
Marketcap
S$116.86
Share price
0.17%
Change (1 day)
32.04%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): S$3.98

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$3.93. In 2024 the company made an earnings per share (EPS) of S$2.94 an increase over its 2023 EPS that were of S$2.49.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$3.9835.42%
2024S$2.9418.23%
2023S$2.4981.13%
2022S$1.37631.03%
2021S$0.19-88.11%
2020S$1.58136.89%
2019S$0.67-39.41%
2018S$1.10-28.27%
2017S$1.54-14.37%
2016S$1.7924.11%
2015S$1.44127.55%
2014S$0.63-51.96%
2013S$1.32-58.95%
2012S$3.22-32.2%
2011S$4.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Bristol-Myers Squibb
BMY
S$3.85-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.23-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$4.66 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
S$4.80 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
S$26.59 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.53 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.44 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.24 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.54 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland